These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 3156220

  • 41. Secondary ossification center of transverse process: a bone-scan normal variant.
    Shore RM, Cain GP, Lloyd TV.
    Eur J Nucl Med; 1985; 10(1-2):88-9. PubMed ID: 3156742
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Study on the distribution features of bone metastases in prostate cancer.
    Wang C, Shen Y.
    Nucl Med Commun; 2012 Apr; 33(4):379-83. PubMed ID: 22293499
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Utility of SPECT imaging for determination of vertebral metastases in patients with known primary tumors.
    Bushnell DL, Kahn D, Huston B, Bevering CG.
    Skeletal Radiol; 1995 Jan; 24(1):13-6. PubMed ID: 7709245
    [Abstract] [Full Text] [Related]

  • 46. Characteristic appearance of facet osteoarthritis of the lower lumbar spine on planar bone scintigraphy with a high negative predictive value for metastasis.
    Kim CK, Park KW.
    Clin Nucl Med; 2008 Apr; 33(4):251-4. PubMed ID: 18356661
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Value of SPECT imaging of the thoracolumbar spine in cancer patients.
    Delpassand ES, Garcia JR, Bhadkamkar V, Podoloff DA.
    Clin Nucl Med; 1995 Dec; 20(12):1047-51. PubMed ID: 8674287
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
    Fosså SD, Winderen M.
    Radiother Oncol; 1993 Apr; 27(1):63-5. PubMed ID: 8327735
    [Abstract] [Full Text] [Related]

  • 52. [Whole body bone scintigram with 99mTc-HMDP (technetium-99m-hydroxy methylene diphosphonate) (author's transl)].
    Isobe Y, Ko S, Umegaki Y, Takahashi S, Kawaguchi N, Wada S, Matsumoto S.
    Radioisotopes; 1981 Nov; 30(11):606-8. PubMed ID: 7335900
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA, Coupal JJ, Kim EE, Blake JS, DeLand FH.
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Bone-to-bone, joint-to-bone and joint-to-joint ratios in normal and diseased skeletal states using region-of-interest technique and bone-seeking radiopharmaceuticals.
    Büll U, Schuster H, Pfeifer JP, Tongendorff J, Niendorf HP.
    Nuklearmedizin; 1977 Jul; 16(3):104-12. PubMed ID: 197499
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. What causes uptake of technetium-99m methylene diphosphonate by tumors? A case where the tumor appeared to secrete a hypercalcemia-causing substance.
    Stone CK, Sisson JC.
    J Nucl Med; 1985 Mar; 26(3):250-3. PubMed ID: 3156221
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.